Jörg Moelleken

1.0k total citations
12 papers, 758 citations indexed

About

Jörg Moelleken is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology. According to data from OpenAlex, Jörg Moelleken has authored 12 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Cell Biology. Recurrent topics in Jörg Moelleken's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Cellular transport and secretion (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Jörg Moelleken is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Cellular transport and secretion (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Jörg Moelleken collaborates with scholars based in Germany, Switzerland and Sweden. Jörg Moelleken's co-authors include Felix Wieland, Julien Béthune, Jörg T. Regula, Ingeborg Reckmann, Yeo Sia Wey, Pamela Strassburger, Chui Ming Gemmy Cheung, Daiju Iwata, Sai Bo Bo Tun and David T. Shima and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Jörg Moelleken

12 papers receiving 737 citations

Peers

Jörg Moelleken
Steven Pennock United States
Peter Baciu United States
Eunkyung An United States
Rose Marie Nagy United States
Matthew Lovatt Singapore
L. M. Gardner United States
Sahana Bose United States
Jeff Bailey United States
Ju He United States
Xinzheng V. Guo United States
Steven Pennock United States
Jörg Moelleken
Citations per year, relative to Jörg Moelleken Jörg Moelleken (= 1×) peers Steven Pennock

Countries citing papers authored by Jörg Moelleken

Since Specialization
Citations

This map shows the geographic impact of Jörg Moelleken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Moelleken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Moelleken more than expected).

Fields of papers citing papers by Jörg Moelleken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Moelleken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Moelleken. The network helps show where Jörg Moelleken may publish in the future.

Co-authorship network of co-authors of Jörg Moelleken

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Moelleken. A scholar is included among the top collaborators of Jörg Moelleken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Moelleken. Jörg Moelleken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gassner, Christian, Robert Karlsson, Florian Lipsmeier, & Jörg Moelleken. (2018). Beyond conventional dose-response curves: Sensorgram comparison in SPR allows single concentration activity and similarity assessment. Journal of Pharmaceutical and Biomedical Analysis. 154. 57–65. 4 indexed citations
3.
Regula, Jörg T., Peter Lundh von Leithner, Richard M. FOXTON, et al.. (2017). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 9(7). 985–985. 7 indexed citations
4.
Gassner, Christian, et al.. (2016). SPR-based assays enable the full functional analysis of bispecific molecules. Journal of Pharmaceutical and Biomedical Analysis. 132. 141–147. 8 indexed citations
5.
Regula, Jörg T., Peter Lundh von Leithner, Richard Foxton, et al.. (2016). Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases. EMBO Molecular Medicine. 8(11). 1265–1288. 241 indexed citations
6.
Gassner, Christian, et al.. (2014). Development and validation of a novel SPR-based assay principle for bispecific molecules. Journal of Pharmaceutical and Biomedical Analysis. 102. 144–149. 21 indexed citations
7.
Fischer, Jens A. A., Axel J. Hueber, Wolfgang Baum, et al.. (2014). Combined Inhibition of Tumor Necrosis Factor α and Interleukin‐17 As a Therapeutic Opportunity in Rheumatoid Arthritis: Development and Characterization of a Novel Bispecific Antibody. Arthritis & Rheumatology. 67(1). 51–62. 139 indexed citations
8.
Beck, Rainer, et al.. (2008). Differential roles of ArfGAP1, ArfGAP2, and ArfGAP3 in COPI trafficking. The Journal of Cell Biology. 183(4). 725–735. 55 indexed citations
9.
Moelleken, Jörg, Jörg Malsam, Matthew J. Betts, et al.. (2007). Differential localization of coatomer complex isoforms within the Golgi apparatus. Proceedings of the National Academy of Sciences. 104(11). 4425–4430. 67 indexed citations
10.
Béthune, Julien, Felix Wieland, & Jörg Moelleken. (2006). COPI-mediated Transport. The Journal of Membrane Biology. 211(2). 65–79. 98 indexed citations
11.
Theis, Mirko, et al.. (2004). Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2. Proceedings of the National Academy of Sciences. 101(31). 11221–11226. 53 indexed citations
12.
Moelleken, Jörg, et al.. (2003). The Tyrosine Kinase Pyk2 Regulates Arf1 Activity by Phosphorylation and Inhibition of the Arf-GTPase-activating Protein ASAP1. Journal of Biological Chemistry. 278(32). 29560–29570. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026